Common variants of the thyroglobulin gene are associated with differentiated thyroid cancer risk

Thyroid

Volumn 21, Issue 5, 2011, Pages 519-525

  Akdi, Abdelmounaim ^a   Pérez, Gisselle ^a,b   Pastor, Susana ^a,c   Castell, Juan ^d   Biarnés, Josefina ^e   Marcos, Ricard ^a,c   Velázquez, Antonia ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL JOSEP TRUETA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTIRELIN RECEPTOR; THYROGLOBULIN;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CHROMOSOME 8Q; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; EXON; FEMALE; GENE CLUSTER; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 8; EXONS; FEMALE; GENE EXPRESSION REGULATION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; THYROGLOBULIN; THYROID NEOPLASMS;

EID: 79957470895     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2010.0384     Document Type: Article

References (28)

1. Sherman SI 2003 Thyroid carcinoma. Lancet 361:501-511. (Pubitemid 36173719)
2. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292-306.
3. Sturgis EM, Li G 2009 Molecular epidemiology of papillary thyroid cancer: in search of common genetic associations. Thyroid 19:1031-1034.
4. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la CA, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.
5. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S, Pita G, Milne R, Maravall J, Ramos I, Andia V, Rodriguez-Poyo P, Jara-Albarran A, Meoro A, del PC, Arribas L, Iglesias P, Caballero J, Serrano J, Pico A, Pomares F, Gimenez G, Lopez-Mondejar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodriguez-Antona C, Gonzalez-Neira A, Matias-Guiu X, Santisteban P, Robledo M 2009 The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5:e1000637.
6. Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la CA 2008 Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 105:7269-7274. (Pubitemid 351754467)
7. Baida A, Akdi M, Gonzalez-Flores E, Galofre P, Marcos R, Velazquez A 2008 Strong association of chromosome 1p12 loci with thyroid cancer susceptibility. Cancer Epidemiol Biomarkers Prev 17:1499-1504.
8. Akdi A, Gimenez EM, Garcia-Quispes W, Pastor S, Castell J, Biarnes J, Marcos R, Velazquez A 2010 WDR3 gene haplotype is associated with thyroid cancer risk in a Spanish population. Thyroid 20:803-809.
9. Yeager M, Orr N, Hayes RB, Jacobs KB, Kraft P, Wacholder S, Minichiello MJ, Fearnhead P, Yu K, Chatterjee N, Wang Z, Welch R, Staats BJ, Calle EE, Feigelson HS, Thun MJ, Rodriguez C, Albanes D, Virtamo J, Weinstein S, Schumacher FR, Giovannucci E, Willett WC, Cancel-Tassin G, Cussenot O, Valeri A, Andriole GL, Gelmann EP, Tucker M, Gerhard DS, Fraumeni JF Jr, Hoover R, Hunter DJ, Chanock SJ, Thomas G 2007 Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39: 645-649. (Pubitemid 46676108)
10. Wokolorczyk D, Gliniewicz B, Sikorski A, Zlowocka E, Masojc B, Debniak T, Matyjasik J, Mierzejewski M, Medrek K, Oszutowska D, Suchy J, Gronwald J, Teodorczyk U, Huzarski T, Byrski T, Jakubowska A, Gorski B, van de WT, Walczak S, Narod SA, Lubinski J, Cybulski C 2008A range of cancers is associated with the rs6983267 marker on chromosome 8. Cancer Res 68:9982-9986.
11. He H, Nagy R, Liyanarachchi S, Jiao H, Li W, Suster S, Kere J, de la CA 2009A susceptibility locus for papillary thyroid carcinoma on chromosome 8q24. Cancer Res 69:625-631.
12. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH 1996 Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102. (Pubitemid 26199756)
13. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T 1998 Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 153:141-148. (Pubitemid 28317516)
14. Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y 2003 Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A 100:15119-15124. (Pubitemid 37518026)
15. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. (Pubitemid 40202029)
16. Sole X, Guino E, Valls J, Iniesta R, Moreno V 2006 SNPStats: a web tool for the analysis of association studies. Bioinformatics 22:1928-1929. (Pubitemid 44283043)
17. Skol AD, Scott LJ, Abecasis GR, Boehnke M 2006 Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38:209-213. (Pubitemid 43177235)
18. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, Jakobsdottir M, Kostic J, Magnusdottir DN, Ghosh S, Agnarsson K, Birgisdottir B, Le RL, Olafsdottir A, Blondal T, Andresdottir M, Gretarsdottir OS, Bergthorsson JT, Gudbjartsson D, Gylfason A, Thorleifsson G, Manolescu A, Kristjansson K, Geirsson G, Isaksson H, Douglas J, Johansson JE, Balter K, Wiklund F, Montie JE, Yu X, Suarez BK, Ober C, Cooney KA, Gronberg H, Catalona WJ, Einarsson GV, Barkardottir RB, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K 2006A common variant associated with prostate cancer in European and African populations. Nat Genet 38:652-658. (Pubitemid 43927306)
19. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, Oakley-Girvan I, Whittemore AS, Cooney KA, Ingles SA, Altshuler D, Henderson BE, Reich D 2006 Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci U S A 103:14068-14073. (Pubitemid 44452981)
20. Schumacher FR, Feigelson HS, Cox DG, Haiman CA, Albanes D, Buring J, Calle EE, Chanock SJ, Colditz GA, Diver WR, Dunning AM, Freedman ML, Gaziano JM, Giovannucci E, Hankinson SE, Hayes RB, Henderson BE, Hoover RN, Kaaks R, Key T, Kolonel LN, Kraft P, Le Marchand L, Ma J, Pike MC, Riboli E, Stampfer MJ, Stram DO, Thomas G, Thun MJ, Travis R, Virtamo J, Andriole G, Gelmann E, Willett WC, Hunter DJ 2007A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 67:2951-2956. (Pubitemid 46724830)
21. Tomlinson I, Webb E, Carvajal-Carmona L, Broderick P, Kemp Z, Spain S, Penegar S, Chandler I, Gorman M, Wood W, Barclay E, Lubbe S, Martin L, Sellick G, Jaeger E, Hubner R, Wild R, Rowan A, Fielding S, Howarth K, Silver A, Atkin W, Muir K, Logan R, Kerr D, Johnstone E, Sieber O, Gray R, Thomas H, Peto J, Cazier JB, Houlston R 2007Agenome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39:984-988.
22. Fletcher O, Johnson N, Gibson L, Coupland B, Fraser A, Leonard A, dos Santos Silva I, Ashworth A, Houlston R, Peto J 2008 Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol Biomarkers Prev 17:702-705. (Pubitemid 351469223)
23. Yamada M, Mori M 2008 Mechanisms related to the pathophysiology and management of central hypothyroidism. Nat Clin Pract Endocrinol Metab 4:683-694.
24. Collu R, Tang J, Castagne J, Lagace G, Masson N, Huot C, Deal C, Delvin E, Faccenda E, Eidne KA, Van Vliet G 1997A novel mechanism for isolated central hypothyroidism: inactivating mutations in the thyrotropin-releasing hormone receptor gene. J Clin Endocrinol Metab 82:1561-1565. (Pubitemid 27200435)
25. Liu XG, Tan LJ, Lei SF, Liu YJ, Shen H, Wang L, Yan H, Guo YF, Xiong DH, Chen XD, Pan F, Yang TL, Zhang YP, Guo Y, Tang NL, Zhu XZ, Deng HY, Levy S, Recker RR, Papasian CJ, Deng HW 2009 Genome-wide association and replication studies identified TRHR as an important gene for lean body mass. Am J Hum Genet 84:418-423.
26. Vono-Toniolo J, Rivolta CM, Targovnik HM, Medeiros-Neto G, Kopp P 2005 Naturally occurring mutations in the thyroglobulin gene. Thyroid 15:1021-1033. (Pubitemid 41475712)
27. Caputo M, Rivolta CM, Esperante SA, Gruneiro-Papendieck L, Chiesa A, Pellizas CG, Gonzalez-Sarmiento R, Targovnik HM 2007 Congenital hypothyroidism with goitre caused by new mutations in the thyroglobulin gene. Clin Endocrinol (Oxf ) 67:351-357. (Pubitemid 47283829)
28. Matakidou A, Hamel N, Popat S, Henderson K, Kantemiroff T, Harmer C, Clarke SE, Houlston RS, Foulkes WD 2004 Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene. Carcinogenesis 25:369-373. (Pubitemid 38344403)